Guillermo Escobar, MD
Vascular Surgery · Little Rock, ARNPI 1427104025
Payments from drug & device makers
What this record shows
10 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 43.5% of the total. Reporting peaked in 2019 at $2,196 and has fallen 82.0% since, to $395 in 2025.
Across 32 payments — averaging $116.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$2K
- Silk Road Medical, Inc.$856
- Bolton Medical Inc$402
- Penumbra, Inc.$325
- Cook Medical LLC$294
- Shockwave Medical, Inc$100
- plus $135 from 4 others
Across 5 payments — averaging $8535.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bard Peripheral Vascular, Inc.$27K
- Medtronic$16K
What the payments were for
- Travel & lodging$1,65444%
- Food & beverage$2,08556%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 10 | $1,627 |
| Silk Road Medical, Inc. | 6 | $856 |
| Bolton Medical Inc | 5 | $402 |
| Penumbra, Inc. | 3 | $325 |
| Cook Medical LLC | 3 | $294 |
| Shockwave Medical, Inc | 1 | $100 |
| Boston Scientific | 1 | $50 |
| Medtronic | 1 | $33 |
| Lemaitre Vascular, Inc. | 1 | $30 |
| Johnson & Johnson | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$770
- ENROUTE Transcarotid Stent System$770
- ENHANCE Transcarotid Peripheral Access Kit$770
- ENROUTE 0.014 Guidewire$770
- EXCLUDER AAA Endoprosthesis$613
- TAG Thoracic Endoprosthesis$325
- GORE TAG Thoracic Endoprosthesis$200
- RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$174
- Indigo System$148
- Penumbra System$134
- Cook Medical Aortic Intervention$129
- GORE VIABAHN VBX Balloon Expandable Endo$122
- GORE VIABAHN Endoprosthesis$113
- TREO ABDOMINAL STENT-GRAFT SYSTEM$104
How this compares
Too few vascular surgery providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 18 | $22,591 |
| EliquisApixaban | 25 | $20,616 |
| BrilintaTicagrelor | 13 | $8,305 |
| Cilostazol | 69 | $1,471 |
| ClopidogrelClopidogrel Bisulfate | 86 | $650 |
| Nifedipine ErNifedipine | 12 | $536 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 12 | $383 |
| Carvedilol | 20 | $358 |
| Gabapentin | 16 | $296 |
| Clonidine Hcl | 13 | $256 |
| Atorvastatin Calcium | 27 | $211 |
| Rosuvastatin Calcium | 14 | $151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $22 | $22,59118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few vascular surgery providers in Arkansason file to place this against a meaningful peer group, so we don't.
Other vascular surgery in Little Rock
- Mohammed MoursiLittle Rock$116K
- Kalenda KasanganaLittle Rock$15K
- Kyla Shelton LangLittle Rock$14K
- Andre RamdonLittle Rock$10K
- Lauren Story-HeftaLittle Rock$9K
- Christian SimmonsLittle Rock$8K
- Steven MeadorsLittle Rock$8K
- Oleksiy GudzLittle Rock$3K
- Ulugbek NegmadjanovLittle Rock$2K
- Robert CasaliLittle Rock$21
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.